Tel Aviv - Delayed Quote ILA

BrainsWay Ltd. (BWAY.TA)

961.00 -11.90 (-1.22%)
At close: April 25 at 2:24 PM GMT+3
Key Events
Loading Chart for BWAY.TA
DELL
  • Previous Close 972.90
  • Open 972.90
  • Bid --
  • Ask 905.40 x --
  • Day's Range 951.00 - 967.70
  • 52 Week Range 272.00 - 1,401.00
  • Volume 107,565
  • Avg. Volume 69,763
  • Market Cap (intraday) 319.763M
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.49
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.60

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

www.brainsway.com

134

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BWAY.TA

Performance Overview: BWAY.TA

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BWAY.TA
15.63%
TA-125
3.84%

1-Year Return

BWAY.TA
208.31%
TA-125
12.73%

3-Year Return

BWAY.TA
29.70%
TA-125
14.72%

5-Year Return

BWAY.TA
52.66%
TA-125
31.24%

Compare To: BWAY.TA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BWAY.TA

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    317.53M

  • Enterprise Value

    145.95M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.64

  • Price/Book (mrq)

    2.03

  • Enterprise Value/Revenue

    4.59

  • Enterprise Value/EBITDA

    -56.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.20%

  • Return on Assets (ttm)

    -4.86%

  • Return on Equity (ttm)

    -9.65%

  • Revenue (ttm)

    31.79M

  • Net Income Avi to Common (ttm)

    -4.2M

  • Diluted EPS (ttm)

    -0.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.98M

  • Total Debt/Equity (mrq)

    1.13%

  • Levered Free Cash Flow (ttm)

    -1.65M

Research Analysis: BWAY.TA

Analyst Price Targets

12.60 Low
12.60 Average
961.00 Current
12.60
 

Earnings

Consensus EPS
 

Company Insights: BWAY.TA

People Also Watch